BASI Bioanalytical Systems Inc

On October 25, 2022, the Board of Directors of Inotiv, Inc. (the “Company”) appointed Brennan Freeman, age 35, as Vice President – Finance and Corporate Controller of the Company. Mr. Freeman will also serve as the Company’s principal accounting officer. Prior to Mr. Freeman’s appointment, Beth Taylor, the Company’s Chief Financial Officer, also served as the Company’s principal accounting officer. Ms. Taylor continues to serve as the Company’s Chief Financial Officer and principal financial officer.

Mr. Freeman has served as the Corporate Controller of the Company since July 12, 2021. Mr. Freeman began his career at Ernst & Young LLP, where he held various positions, including most recently as Manager – Global Life Sciences Assurance Resident from July 2018 to September 2018, Senior Manager – Global Life Sciences Assurance Resident from October 2018 – June 2020 and Senior Manager – Assurance Services from July 2020 – July 2021.

Under the terms of Mr. Freeman’s employment, he is entitled to receive an annual base salary of $225,750 and a discretionary annual incentive bonus which is tied to company performance metrics and individual achievements. Mr. Freeman is also entitled to participate in the Company’s equity and benefit plans and programs provided to Company executives generally, subject to eligibility requirements and the other terms and conditions of those plans and programs.

There are no arrangements or understandings between Mr. Freeman and any other persons pursuant to which he was selected as an officer, and he has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.